Strides Pharma Science successfully concludes WHO inspection at Puducherry facility

Bengaluru: Strides Pharma Science Limited has announced that the company has successfully completed the inspection carried out by the World Health Organization (WHO) at its Puducherry facility.

The inspection was held between 16-20 January 2023.

The Puducherry facility caters to the U.S., Other Regulated Markets, and Institutional businesses and can produce finished dosage formulation products across multiple dosage formats.

Medical Dialogues team had earlier reported that the company had successfully concluded the EU GMP inspection carried out by the National Institute of Pharmacy and Nutrition (OGYÉI), Hungry at its Puducherry facility.

Read also: Strides Pharma successfully completes EU GMP inspection of Puducherry facility